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Summary
Nimodipine (nmd) is a drug used as cerebral vasodilator whose physicochemical 
properties in solution have not been studied completely. In this work the Extended 
Hildebrand Solubility Approach (ehsa) was applied to evaluate the equilibrium 
solubility of nmd in some polyethylene glycol 400 + ethanol mixtures at 298.15 K. 
An acceptable correlative capacity of ehsa was found using a regular polynomial 
model in order three (overall deviation lower than 1.3%), when the W interaction 
parameter is related to the solubility parameter of the mixtures. Moreover, the mean 
deviation obtained in the estimated solubility with respect to experimental solu-
bility was lower than the one obtained directly by means of an empiric regression 
in order three of the logarithm experimental solubility as a function of the mixtures’ 
solubility parameters (1.7%).
Key words: Nimodipine, PEG 400 + ethanol, Extended Hildebrand Solubility 
Approach, binary mixtures, solubility parameter.
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Resumen
Método extendido de Hildebrand aplicado a la solubilidad de 
nimodipina en mezclas PEG 400 + etanol
La nimodipina (nmd) es un agente usado como vasodilatador cerebral y cuyas 
propiedades fisicoquímicas en solución aún no han sido totalmente estudiadas. En 
la presente investigación se aplicó el Método Extendido de Solubilidad de Hilde-
brand (mesh) al estudio de la solubilidad de nmd en algunas mezclas binarias PEG 
400 + etanol a 298,15 K. Se obtuvo una capacidad predictiva aceptable del mesh 
(desviación general inferior al 1,3%) al utilizar un modelo polinómico regular de 
tercer orden, relacionando el parámetro de interacción W con el parámetro de 
solubilidad de las mezclas solventes. De esta forma, las desviaciones obtenidas en 
la solubilidad estimada fueron de magnitud inferior a las obtenidas al calcular esta 
propiedad directamente, utilizando una regresión empírica regular del mismo orden, 
de la solubilidad experimental del fármaco en función del parámetro de solubilidad 
de las mezclas disolventes, en la cual se obtuvo una desviación promedio del 1,7%.
Palabras clave: nimodipina, PEG 400 + etanol, Método Extendido de Solubilidad 
de Hildebrand, mezclas binarias, parámetro de solubilidad.
Introduction
Nimodipine (nmd, Figure 1, molar mass 418.44 g mol-1) is a calcium channel blocker 
that prevents the calcium-dependent smooth muscle contraction and therefore, the 
subsequent vasoconstriction. nmd exhibits greater effects on cerebral circulation 
than on peripheral circulation, and for this reason, it is specially used as an adjunct to 
improve the neurologic outcome following subarachnoid hemorrhage from ruptured 
intracranial aneurysm [1]. 
On the other hand, nmd aqueous solubility is too low to allow the design of homo-
geneous liquid dosage forms with solvents strictly aqueous [2]. For this reason some 
disperse and coarse dosage systems have been investigated and developed, which 
include liposomes [3], solid dispersions [4, 5], cyclodextrin inclusion complexes [6-8], 
hydrogels and hydrophilic matrices [9, 10], and some emulsions [11]. Nevertheless, in 
every one of these formulations this drug is dispersed only in a coarse way instead of 
a molecular one as a real solution. In the Colombian market this drug is presented as 
tablets, injectable and soft gelatin capsules [12].
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Figure 1. Molecular structure of nimodipine.
Although nmd is used in therapeutics, the physicochemical information about its 
solubility is not abundant. In this way, it is important to note that cosolvency is the 
best technique used in pharmacy for increasing drugs solubility to develop homoge-
neous liquid dosage forms [13]. On the other hand, it is clear that predictive methods 
of physicochemical properties of drugs are very important for industrial pharmacists 
because they allow optimizing design processes [14].
For this reason, this work presents a physicochemical study about the solubility predic-
tion of nmd in binary mixtures conformed by polyethylene glycol 400 (PEG 400) and 
ethanol. The study was done based on the Extended Hildebrand Solubility Approach 
(ehsa) [15]. Up to the best of our knowledge no report about the application of ehsa 
method to this drug has been presented in the literature. It is relevant to keep in mind 
that ehsa method has been widely used to study the solubility of a lot of pharmaceuti-
cal compounds [16-38]. On the other hand, PEG 400 is, after ethanol and propylene 
glycol, the cosolvent more employed to develop liquid pharmaceutical dosage forms 
[39]. Moreover, PEG 400 is also employed to regulate the evaporation in liquid prod-
ucts [40].
Theoretical
The real solubility (X2) of a solid solute in a liquid solution is calculated adequately by 
means of the expression,
− =
−( )
+log . logX
H T T
RT T
fus fus
fus
2 22 303

  (Eq. 1)
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where, H fus is the fusion enthalpy of the solute, R is the gas constant, Tfus is the melt-
ing point of the solute, T is the absolute temperature of the solution, and log 2 is the 
non-ideality term. It is important to keep in mind that ideal solubility is calculated by 
means of Equation 1 without consider the second term of the right side. The 2 term is 
the activity coefficient of the solute determined experimentally. One method of calcu-
lating 2 is the referent to regular solutions obtained from,
− =
−( )
+ −( )log . .X
H T T
RT T
V
RT
fus fus
fus
2
2 1
2
1 2
2
2 303 2 303
     (Eq. 2)
where, V2 is the partial molar volume of the solute, 1 is the volume fraction of the 
solvent in the saturated solution, and 1 and 2 are the solubility parameters of solvent 
and solute, respectively. Pharmaceutical dissolutions deviate of predicted by the regular 
solutions theory. On this way, Martin et al. developed the ehsa method (16-22). If the 
A term (defined as V RT2 1
2 2 303 /( . )) is introduced in the equation 3, the real solubil-
ity of drugs can be calculated from the expression,
− = − + + −( )log logX X A Wid2 2 12 22 2   (Eq. 3)
where, the W term is equal to 2 1 2K    (where, K is the Walker parameter). The W fac-
tor can be calculated from experimental data by means of,
W A= × + −



0 5 1
2
2
2 2.
log    (Eq. 4)
where, 2 is the activity coefficient of the solute in the saturated solution, and it is 
calculated as, X Xid2 2/ . The experimental values of the W parameter can be correlated 
by means of regression analysis by using regular polynomials as a function of 1, as fol-
lows,
W C C C C Cn
n= + + + +0 1 1 2 12 3 13 1   .....  (Eq. 5)
These empiric models can be used to estimate the drug solubility by means of back-
calculation resolving this property from the specific W value obtained in the respective 
polynomial regression. A lot of examples of the application of the previous equations 
have been reported in the literature [15-38].
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Experimental
Reagents
Nimodipine (1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic 
acid 2-methoxyethyl 1-methylethyl ester; CAS No. 66085-59-4; Haohua Ind. & Co., 
China), polyethylene glycol 400 (Dow Chemical Co., usa), and absolute ethanol A.R. 
(Merck, Germany), used in this research, were in agreement with the quality require-
ments of the American Pharmacopeia, USP [41].
Solvent mixtures preparation
Both solvents were dried by using molecular sieve (Merck, 3 Å) before preparing the 
mixtures. All PEG 400 + ethanol mixtures were prepared by mass, using an Ohaus 
Pioneer TM PA214 analytical balance with sensitivity of ± 0.1 mg, in quantities of 50 
g. The mass fractions of PEG 400 of the nine binary mixtures prepared varied by 0.10 
from 0.10 to 0.90.
Solubility determinations
An excess of nmd was added to approximately 10 g of each solvent mixture or neat 
solvents, in stoppered dark glass flasks. The flasks with the solid-liquid mixtures were 
placed in re-circulating thermostatic baths (Neslab RTE 10 Digital One Thermo Elec-
tron Company) kept at 298.15 ± 0.05 K for at least 7 days to reach the equilibrium. 
After this time the supernatant solutions were filtered at isothermal conditions (Mil-
lipore Corp. Swinnex®-13) to ensure that they were free of particulate matter before 
sampling for composition analysis. nmd concentrations were determined by UV-spec-
trophotometric analysis at 236 nm after alcoholic dilution. All the solubility experi-
ments were run at least in triplicates. In order to transform mole fractions to molar 
concentrations (mol dm-3), the density of the saturated solutions was determined with 
a digital density meter (DMA 45 Anton Paar) connected to the same re-circulating 
thermostatic baths [42].
Calorimetric study
Melting point and enthalpy of fusion of nmd were determined by DSC studies (DSC 
823E Mettler Toledo). Thermal analyses were performed at a heating rate of 10 K min-1 
in a dynamic nitrogen atmosphere (60 cm3 min-1). Nearly 1.5 mg of drug was used. The 
equipment was calibrated using Indium as standard [43].
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Estimation of the volumetric contributions
Apparent specific volume Vspc( )  were calculated according to equation 6, where, m2 
and m1 are the masses of solute and solvent in the saturated solution, respectively, VE1 
is the specific volume of the solvent, and soln is the solution density [44].


V
m m VE
m
spc soln
soln
= + −( )2 1 1
2
1
 (Eq. 6)
The nmd apparent molar volume is calculated by multiplying the Vspc  value and the 
molar mass of the solute.
Results and discussion
The information about polarity and volumetric behavior of PEG 400 + ethanol mixtures as 
a function of the composition is shown in Table 1 [45]. On the other hand, the calorimet-
ric values of fusion for nmd were as follows, Tfus = 397.2 K and ∆H fus =
− 41 68 kJ mol 1. . 
From these values the calculated ideal solubility for this drug calculated by using Equation 
7 was 1.513  10–2 in mole fraction. 
− =
−( )
log .X
H T T
RT T
id fus fus
fus
2 2 303

 (Eq. 7)
Table 1 also summarizes the nmd solubility expressed in molarity and mole fraction, 
the density of the saturated mixtures, the apparent molar volume of nmd, and the 
solvent volume fraction in the saturated solutions at 298.15 K. It is interesting to 
note that when molarity is considered the maximum drug solubility is obtained in 
the mixture with 1 1 224  MPa= . /00  (0.7367 in volume fraction of PEG 400) but if 
the mole fraction scale is considered the maximum is obtained in neat PEG 400 (with 
1 1 223 1  MPa= . /0 ). This result is a consequence of the definition of each concentra-
tion scale [15]. Nevertheless, in this case the useful scale is mole fraction.
From density values of cosolvent mixtures and saturated solutions, in addition to nmd 
solubility, the solvent volume fraction 1( ) and apparent molar volume of the solute 
Vmol( ) in the saturated mixtures, were calculated. These values are also presented in 
Table 1.
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Table 1. PEG 400 + ethanol solvent mixtures composition, Hildebrand solubility parameter of mix-
tures, nimodipine solubility expressed in molarity and in mole fraction, density of the solvents and 
saturated mixtures, apparent molar volume of nimodipine, solvent volume fraction in the saturated 
solutions, and activity coefficient of nimodipine as decimal logarithm, at 298.15 K.
PEG
1 a/
MPa1/2
nmd
solv c/
g cm-3
 satd soln/
g cm-3
Vmol /
cm3 mol-1
1 log 2mol 
dm-3 X2 %VC
b
0.0000 26.50 0.115 6.93 E-3 1.51 0.7853 0.8067 295.6 0.9660 0.339
0.0721 26.25 0.133 8.58 E-3 2.61 0.8148 0.8322 353.0 0.9530 0.246
0.1489 25.99 0.162 1.12 E-2 0.98 0.8438 0.8624 359.2 0.9420 0.129
0.2307 25.72 0.193 1.47 E-2 2.30 0.8726 0.8930 358.4 0.9309 0.014
0.3181 25.42 0.225 1.89 E-2 1.19 0.9041 0.9255 357.5 0.9196 -0.097
0.4116 25.10 0.245 2.31 E-2 0.10 0.9360 0.9610 338.4 0.9169 -0.183
0.5121 24.76 0.255 2.77 E-2 2.40 0.9693 0.9883 355.1 0.9093 -0.262
0.6201 24.39 0.279 3.59 E-2 1.93 1.0044 1.0236 348.1 0.9030 -0.375
0.7367 24.00 0.289 4.64 E-2 2.07 1.0419 1.0569 351.8 0.8984 -0.487
0.8630 23.57 0.284 6.19 E-2 1.69 1.0815 1.0915 354.2 0.8994 -0.612
1.0000 23.10 0.267 9.52 E-2 1.87 1.1224 1.1282 353.6 0.9055 -0.799
a  1 values were calculated additively according to 1 = PEGPEG + (1–PEG)EtOH, where PEG is the volume fraction of PEG 
400 and PEG and EtOH are the Hildebrand solubility parameters of PEG 400 (23.1 MPa1/2) and ethanol (26.5 MPa1/2), 
respectively [14].
b  %VC is the percentage variation coefficient of solubility values.
c  Data from Rodríguez et al. [44].
Ultimately, the activity coefficients of nmd as decimal logarithms are also presented 
in Table 1. These values were calculated from experimental solubility values and ideal 
solubility at 298.15 K X2
21 513 1= ×( )−. 0 . In the vast majority of cases, 2 values were 
lower than unit (negative logarithmic values) because in those systems (PEG 400-rich 
mixtures) the experimental solubilities are greater than the ideal one.
Because the maximum mole fraction solubility of nmd was obtained in neat PEG 400 
instead of a mixture Table 2 summarizes the results of the application of the group 
contribution method of Fedors for estimate interne energy, molar volume, and total 
Hildebrand solubility parameter of nimodipine, total 1 221 89 MPa= . /  [46]. According 
to this result, it is clear that this drug is less polar than PEG 400, which is the less polar 
solvent employed in this study.
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Figure 2 shows the experimental drug solubility and the calculated solubility by using 
the regular solutions model (Equation 2) as a function of the solubility parameter of 
solvent mixtures. It is interesting to note that the experimental solubility is greater 
than the calculated solubility by using the regular solution model in every one of the 
mixtures evaluated. This result could be attributed to the fact that this semiempirical 
model does not consider specific interactions between solvent and solute, and all the 
involved compounds present polar groups that could interact by hydrogen bonding. In 
particular PEG 400 could interact as Lewis base due to its ether oxygen atoms with the 
amine groups of nmd (Figure 1). Moreover, other possible interactions between etha-
nol and this drug could be present due to their carboxyl and nitro groups (Figure 1).
Table 2. Application of the group contribution method of Fedors for estimate interne energy, molar 
volume, and total Hildebrand solubility parameter of nimodipine.
Group or atom Quantity U / kJ mol-1 V/cm3 mol-1
–CH3 5 5 × 4.71 = 23.54 5 × 33.5 = 167.5
–CH2– 2 2 × 4.94 = 9.87 2 × 16.1 = 32.2
>CH– 2 2 × 3.43 = 6.86 2 × –1.0 = –2.0
>C= 4 4 × 4.31 = 17.24 4 × –5.5 = –22.0
Phenylene (m) 1 31.92 52.4
–COO– 2 2 × 17.99 = 35.98 2 × 18.0 = 36.0
–O– 1 3.35 3.8
–NH– 1 8.37 4.5
–NO2 1 15.36 32.0
Ring closure 1 1.05 16.0
Utotal = 153.54 Vtotal = 320.4
total = (153,540/320.4)1/2 = 21.89 MPa1/2
In order to calculate the W parameter the calculated total value (21.89 MPa1/2, Table 
2) was used [46]. On the other hand, the parameters A, K, and W are presented in 
Table 3. Figure 3 shows that the variation of the W parameter with respect to the solu-
bility parameter of solvent mixtures, presents deviation from linear behavior, just as 
it is expectable because the W term implies the summation of two quadratic terms 
 12 22 and ( ) and one non-constant-quotient involving a logarithmic term −( )log 2 / A  
as it is shown in Equation 4.
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Figure 2. Experimental solubility (0) and calculated solubility according to the regular solutions 
model of Hildebrand () of nimodipine as a function of the solubility parameter of the solvent 
mixtures in PEG 400 + ethanol mixtures at 298.15 K. Discontinuous line is the ideal solubility of 
nimodipine.
Table 3. A, K, and W experimental parameters for nimodipine in PEG 400 + ethanol mixtures at 
298.15 K.
1 / MPa1/2 100 × A / cm3 J-1 K / J cm-3 a Wexpt / J cm-3a
26.50 9.60369 0.507636 588.945
26.25 11.16058 0.507327 583.139
25.99 11.09398 0.506889 576.844
25.72 10.81196 0.506444 570.171
25.42 10.52472 0.506007 563.097
25.10 9.90281 0.505532 555.527
24.76 10.21916 0.504980 547.372
24.39 9.88033 0.504705 538.955
24.00 9.88260 0.504453 529.929
23.57 9.97447 0.504335 520.331
23.10 10.09080 0.504637 510.348
a 1 J cm-3 = 1 MPa.
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W
Figure 3. W parameter as a function of the solubility parameter of the solvent mixtures in PEG 400 
+ ethanol mixtures at 298.15 K.
W values were adjusted to regular polynomials in orders from 2 to 5 (Equation 5). 
Nevertheless linear model was also evaluated with comparative purposes. Table 4 sum-
marizes the coefficients obtained in all the regular polynomials from degrees one to 
five, whereas the W values calculated by using the respective polynomials are presented 
in Table 5. It is well clear that these values depend on the model used in the W back-
calculation. Similar behaviors have been reported in the literature for this drug and for 
several other compounds in different solvent mixtures [16-38].
Table 6 summarizes the solubility values obtained by using the W values obtained by 
back-calculation from the polynomial models (Table 3) and presented in Table 4. In 
the same way as it was made previously [30-32, 34, 36-38] and because we are search-
ing the best adjust, the first criterion used to define the polynomial order of W term 
as function of 1 was the fitting standard uncertainties obtained, whose values were as 
follows, 0.4926, 0.1333, 0.0464, 0.0468, and 0.0496 (Table 4), for orders one to five, 
respectively. So, the best one is obtained by using a polynomial in order 3. As another 
comparison criterion, Table 6 also summarizes the percentages of difference between 
nmd experimental solubility and those calculated by using ehsa.
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Table 4. Coefficients and statistical parameters of regular polynomials in several orders of W as a 
function of solubility parameters of cosolvent mixtures free of nimodipine (Equation 5) in PEG 
400 + ethanol mixtures. Values in parentheses are the respective uncertainties.
Coefficient 
or parameter
Polynomial order
1 2 3 4 5
C0 –28 (3) 232 (24) 1,994 (229) –4,231 (6,589) 118,653 (211,721)
C1 23.25 (0.14) 2.3 (2.0) –211 (28) 795 (1,064) –24,020 (42,747)
C2 - 0.42 (0.04) 9.0 (1.1) –52 (64) 1,951 (3,450)
C3 - - –0.116 
(0.015)
1.5 (1.7) –79 (139)
C4 - - - –1.7 (1.7) E–2 1.6 (2.8)
C5 - - - - –1.3 (2.3) E–2
Adj. r2 0.9996 1.0000 1.0000 1.0000 1.0000
Fit. Err. 0.4926 0.1333 0.0464 0.0468 0.0496
Table 5. W parameters ( J cm-3 a) back-calculated by using several polynomial models for nimodipine 
in PEG 400 + ethanol mixtures at 298.15 K.
1 / MPa1/2
Polynomial order
1 2 3 4 5
26.50 588.461 589.133 588.972 588.956 588.818
26.25 582.759 583.112 583.100 583.111 582.992
25.99 576.692 576.762 576.844 576.861 576.738
25.72 570.225 570.057 570.177 570.188 570.053
25.42 563.316 562.965 563.074 563.073 562.931
25.10 555.919 555.456 555.510 555.498 555.359
24.76 547.980 547.490 547.466 547.451 547.322
24.39 539.437 539.030 538.925 538.919 538.798
24.00 530.219 530.027 529.883 529.894 529.767
23.57 520.242 520.434 520.347 520.369 520.224
23.10 509.408 510.193 510.351 510.339 510.214
a 1 J cm-3 = 1 MPa.
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Table 6. Calculated solubility of nimodipine in PEG 400 + ethanol mixtures by using the W para-
meters obtained from regression models in orders 1, 2, 3, 4 and 5, and difference percentages with 
respect to the experimental values at 298.15 K.
1 (MPa1/2)
X2 calculated % dev. a
1 2 3 4 5 1 2 3 4 5
26.50 5.59 E-3 7.53 E-3 7.01 E-3 6.96 E-3 6.55 E-3 19.3 8.7 1.2 0.5 5.5
26.25 7.06 E-3 8.47 E-3 8.42 E-3 8.46 E-3 7.96 E-3 17.7 1.4 1.9 1.4 7.3
25.99 1.04 E-2 1.08 E-2 1.12 E-2 1.13 E-2 1.07 E-2 7.5 4.1 0.0 0.9 5.3
25.72 1.51 E-2 1.39 E-2 1.47 E-2 1.48 E-2 1.38 E-2 2.7 5.5 0.3 0.9 5.7
25.42 2.10 E-2 1.77 E-2 1.87 E-2 1.87 E-2 1.74 E-2 11.2 6.2 1.1 1.2 7.7
25.10 2.76 E-2 2.23 E-2 2.29 E-2 2.28 E-2 2.14 E-2 19.6 3.2 0.8 1.3 7.4
24.76 3.69 E-2 2.93 E-2 2.89 E-2 2.87 E-2 2.70 E-2 33.1 5.7 4.5 3.8 2.3
24.39 4.46 E-2 3.71 E-2 3.54 E-2 3.53 E-2 3.34 E-2 24.5 3.4 1.4 1.6 6.9
24.00 5.29 E-2 4.85 E-2 4.54 E-2 4.57 E-2 4.31 E-2 14.1 4.6 2.1 1.6 7.1
23.57 5.95 E-2 6.49 E-2 6.24 E-2 6.30 E-2 5.90 E-2 4.0 4.8 0.7 1.7 4.8
23.10 6.15 E-2 8.85 E-2 9.53 E-2 9.48 E-2 8.94 E-2 35.4 7.0 0.1 0.5 6.1
Mean value b 17.2 5.0 1.3 1.4 6.0
Standard 
deviation b 10.8 2.0 1.3 0.9 1.6
a  Calculated as 100 X2 expt – X2 calc/X2 expt. 
b  Calculated considering the obtained values in the neat solvents and the nine binary mixtures.
At the beginning, it is found that as more complex the polynomial used is, better 
the agreement found between experimental and calculated solubility is, reaching the 
maximum concordance using a polynomial in order three. This result is different way 
to those reported in the literature for other pharmaceutical compounds where the 
concordance always increases with the polynomial degree [16-38]. Most important 
increment in concordance is obtained passing from order 1 to order 2, but the more 
significant increment is also obtained from order 2 to order 3. Therefore, in the follow-
ing comparisons the polynomial model in order 3 is used. 
As has been exposed previously, an important consideration about the usefulness of 
the ehsa method is the one referent to justify the complex calculations involving any 
other variables, instead of the simple empiric regression of the experimental solubility 
as a function of the solvent mixtures’ solubility parameters (Table 1, Figure 4). For 
this reason, in the Table 7 the experimental solubilities are confronted to those cal-
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culated directly by using a regular polynomial in order 3 of log X2 as a function of 1 
values (Equation 8, with adjusted determination coefficient r2 = 0.9989 and fitting 
standard uncertainty = 0.0108) and also to those calculated involving the W param-
eters obtained from equation 5 adjusted to order 3 (Tables 4 and 5). The respective 
difference percentages are also presented in Table 7.
log ( ) ( ) . ( . ) . ( . )X2 1 1
2 2
1
3344 54 42 6 1 68 0 26 2 3 0 4 10= ± − ± + ± − ± × −    (Eq. 8)
Table 7. Comparison of the nimodipine solubility values in PEG 400 + ethanol mixtures calculated 
directly and by using the ehsa at 298.15 K.
1 / MPa1/2
X2 % dev. a
Exptl. Calc. direct. b Calc. W 
c Calc. 
direct. Calc. W
26.50 6.93 E-3 6.75 E-3 7.01 E-3 2.6 1.2
26.25 8.58 E-3 8.88 E-3 8.42 E-3 3.4 1.9
25.99 1.12 E-2 1.15 E-2 1.12 E-2 2.1 0.0
25.72 1.47 E-2 1.46 E-2 1.47 E-2 0.3 0.3
25.42 1.89 E-2 1.84 E-2 1.87 E-2 2.9 1.1
25.10 2.31 E-2 2.29 E-2 2.29 E-2 1.0 0.8
24.76 2.77 E-2 2.84 E-2 2.89 E-2 2.6 4.5
24.39 3.59 E-2 3.57 E-2 3.54 E-2 0.5 1.4
24.00 4.64 E-2 4.61 E-2 4.54 E-2 0.7 2.1
23.57 6.19 E-2 6.29 E-2 6.24 E-2 1.6 0.7
23.10 9.52 E-2 9.46 E-2 9.53 E-2 0.6 0.1
Mean value d 1.7 1.3
Standard deviation d 1.1 1.3
a  Calculated as 100 X2 expt – X2 calc/X2 expt. 
b  Calculated using the equation 8. 
c  Calculated using the equation 5 adjusted to order 3 (Tables 4 and 5). 
d  Calculated considering the obtained values in the neat solvents and the nine binary mixtures.
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Figure 4. Logarithmic solubility of nimodipine as a function of the solubility parameter of the sol-
vent mixtures in PEG 400 + ethanol mixtures at 298.15 K. Dotted line is the additive solubility 
behavior.
Based on mean deviation percentages presented in Table 7 (1.7% and 1.3% for direct 
calculation and ehsa method, respectively) it follows that a small difference is found 
between the values obtained by using both methods. The present results would be 
showing a significant usefulness of ehsa method for practical purposes.
On the other hand, it is very interesting to note that this drug exhibit negative and 
positive deviations with respect to ideal log-linear additive model (dotted line in Fig-
ure 4). Nevertheless the molecular reasons for this behavior are unclear due to the lack 
of information about structural effects in these binary mixtures [47, 48].
Conclusion
In this investigation the ehsa method has been adequately used to study the solubility 
of nmd in PEG 400 + ethanol mixtures by using experimental values of molar volume 
and calculated Hildebrand solubility parameter of this drug. In particular, a good pre-
dictive character has been found by using a regular polynomial in order three of the 
interaction parameter W as a function of the solubility parameter of solvent mixtures 
free of solute. This result is different to that reported for other pharmaceutical com-
pounds in terms of polynomial order and fitting obtained. Nevertheless, the predictive 
character is just slightly better than the one obtained by direct correlation between 
solubility and mixtures composition. 
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